Debt-to-equity of Nautilus Biotechnology, Inc. from 30 Jun 2021 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Nautilus Biotechnology, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2021 to 31 Dec 2025.
  • Nautilus Biotechnology, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 19%, a 17% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Nautilus Biotechnology, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 19% +2.7% +17% 31 Dec 2025
Q3 2025 17% +1.7% +11% 30 Sep 2025
Q2 2025 17% +1.4% +9.3% 30 Jun 2025
Q1 2025 16% +1.4% +9.6% 31 Mar 2025
Q4 2024 16% +1.5% +11% 31 Dec 2024
Q3 2024 16% +2.3% +17% 30 Sep 2024
Q2 2024 15% +3% +24% 30 Jun 2024
Q1 2024 15% +3.6% +32% 31 Mar 2024
Q4 2023 14% +4.1% +39% 31 Dec 2023
Q3 2023 13% +3.4% +34% 30 Sep 2023
Q2 2023 12% +4.6% +58% 30 Jun 2023
Q1 2023 11% +5.9% +109% 31 Mar 2023
Q4 2022 10% +5.6% +117% 31 Dec 2022
Q3 2022 10% +6.6% +192% 30 Sep 2022
Q2 2022 7.8% +0.46% +6.3% 30 Jun 2022
Q1 2022 5.4% 31 Mar 2022
Q4 2021 4.8% 31 Dec 2021
Q3 2021 3.4% 30 Sep 2021
Q2 2021 7.3% 30 Jun 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.